Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance

Author： Lu Ellen   Wang Bing Wei   Guimond Colleen   Synnes Anne   Sadovnick A Dessa   Dahlgren Leanne   Traboulsee Anthony   Tremlett Helen  

Publisher： Informa Healthcare

ISSN： 1473-7175

Source： Expert Review of Neurotherapeutics, Vol.13, Iss.3, 2013-03, pp. : 251-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disease-Modifying Antirheumatic Drugs in Pregnancy: Current Status and Implications for the Future

By Vroom Fokaline  

Drug Safety, Vol. 29, Iss. 10, 2006-01 ,pp. : 845-863

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic considerations of multiple sclerosis therapy with the new disease-modifying agents

By Amato Maria Pia  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2115-2126

Informa Healthcare

Access to resources Recommend Favorite

Disease-Modifying Agents for Multiple Sclerosis: Recent Advances and Future Prospects

By Menge Til  

Drugs, Vol. 68, Iss. 17, 2008-01 ,pp. : 2445-2468

Adis International

Access to resources Recommend Favorite

Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 5, 2012-08 ,pp. : 610-623

Bentham Science Publishers

Access to resources Recommend Favorite

Current Considerations for the Effective Safety Evaluation of Drugs In Vitro

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-06 ,pp. : 861-868

Bentham Science Publishers

Access to resources Recommend Favorite